Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

502 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of HBV precore/core promoter variants in the United States.
Chu CJ, Keeffe EB, Han SH, Perrillo RP, Min AD, Soldevila-Pico C, Carey W, Brown RS Jr, Luketic VA, Terrault N, Lok AS; U.S. HBV Epidemiology Study Group. Chu CJ, et al. Hepatology. 2003 Sep;38(3):619-28. doi: 10.1053/jhep.2003.50352. Hepatology. 2003. PMID: 12939588 Free article.
Adefovir dipivoxil therapy for lamivudine-resistant hepatitis B in pre- and post-liver transplantation patients.
Schiff ER, Lai CL, Hadziyannis S, Neuhaus P, Terrault N, Colombo M, Tillmann HL, Samuel D, Zeuzem S, Lilly L, Rendina M, Villeneuve JP, Lama N, James C, Wulfsohn MS, Namini H, Westland C, Xiong S, Choy GS, Van Doren S, Fry J, Brosgart CL; Adefovir Dipovoxil Study 435 International Investigators Group. Schiff ER, et al. Hepatology. 2003 Dec;38(6):1419-27. doi: 10.1016/j.hep.2003.09.040. Hepatology. 2003. PMID: 14647053
Update on chronic hepatitis C.
Wong W, Terrault N. Wong W, et al. Clin Gastroenterol Hepatol. 2005 Jun;3(6):507-20. doi: 10.1016/s1542-3565(05)00247-8. Clin Gastroenterol Hepatol. 2005. PMID: 15952092 Review.
Protective antibody levels and dose requirements for IV 5% Nabi Hepatitis B immune globulin combined with lamivudine in liver transplantation for hepatitis B-induced end stage liver disease.
Dickson RC, Terrault NA, Ishitani M, Reddy KR, Sheiner P, Luketic V, Soldevila-Pico C, Fried M, Jensen D, Brown RS Jr, Horwith G, Brundage R, Lok A. Dickson RC, et al. Among authors: terrault na. Liver Transpl. 2006 Jan;12(1):124-33. doi: 10.1002/lt.20582. Liver Transpl. 2006. PMID: 16382463 Free article. Clinical Trial.
Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.
Su X, Yee LJ, Im K, Rhodes SL, Tang Y, Tong X, Howell C, Ramcharran D, Rosen HR, Taylor MW, Liang TJ, Yang H; Virahep-C Study Group. Su X, et al. J Hepatol. 2008 Aug;49(2):184-91. doi: 10.1016/j.jhep.2008.04.011. Epub 2008 May 20. J Hepatol. 2008. PMID: 18571276 Free PMC article.
502 results